Cefoperazone
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Cefoperazone
Description:
Cefoperazone, a semisynthetic cephalosporin, has a broad spectrum of antibacterial activity[1].UNSPSC:
12352005Hazard Statement:
H317, H334Target:
Antibiotic; BacterialType:
Reference compoundRelated Pathways:
Anti-infectionApplications:
COVID-19-immunoregulationField of Research:
InfectionAssay Protocol:
https://www.medchemexpress.com/cefoperazone.htmlPurity:
99.82Solubility:
DMSO : ≥ 100 mg/mL|H2O : < 0.1 mg/mLSmiles:
O=C (C (N12) =C (CSC3=NN=NN3C) CS[C@]2 ([H]) [C@H] (NC ([C@H] (NC (N4C (C (N (CC) CC4) =O) =O) =O) C5=CC=C (O) C=C5) =O) C1=O) OMolecular Formula:
C25H27N9O8S2Molecular Weight:
645.67Precautions:
H317, H334References & Citations:
[1]N Matsubara, et al. In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin. Antimicrob Agents Chemother. 1979 Dec;16 (6) :731-5.|[2]Pedro H.Di Rocco, et al. Aerosol treatment with cefoperazone or gentamicin protects granulocytopenic mice from acute Pseudomonas aeruginosa pneumonia. European Journal of Pharmaceutical Sciences Volume 1, Issue 6, June 1994, Pages 285-289.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
LaunchedIsoform:
β-lactamCitation 01:
Carbohydr Polym. 2024 Jan 1:323:121379.|J Antibiot (Tokyo) . 2023 Apr;76 (4) :225-235.|Mol Med. 2024 Nov 6;30 (1) :203.|Toxicol Appl Pharmacol. 2023 Apr 1:464:116447.|Carbohydr Polym. 2024 Jan 1:323:121379.CAS Number:
62893-19-0
